These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1492050)

  • 1. Nevi as risk factors for melanoma.
    MacKie RM
    Pediatr Dermatol; 1992 Dec; 9(4):340-1. PubMed ID: 1492050
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dysplastic pigmented nevi as a high risk group for the development of malignant melanoma].
    Kik A; Kowalewska Z; Pawińska M
    Przegl Dermatol; 1986; 73(4):323-6. PubMed ID: 3333866
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nevi are common--they should be treated accordingly].
    Beitner H; Kaaman T; Molin L
    Lakartidningen; 1990 Apr; 87(17):1461-4. PubMed ID: 2187132
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nevi, sun and the risk of melanoma].
    Snellman E; Koulu L; Rantanen T
    Duodecim; 2002; 118(4):359-66; quiz 366, 401. PubMed ID: 12233040
    [No Abstract]   [Full Text] [Related]  

  • 5. Melanoma precursors in children.
    Lefkowitz A; Schwartz RA; Janniger CK
    Cutis; 1999 Jun; 63(6):321-4. PubMed ID: 10388950
    [No Abstract]   [Full Text] [Related]  

  • 6. Precursors of malignant melanoma. Problems in computing the risk of malignant melanoma arising in dysplastic and congenital nevocytic nevi.
    Rigel DS; Friedman RJ; Kopf AW; Rogers GS; Heilman ER
    Dermatol Clin; 1985 Apr; 3(2):361-5. PubMed ID: 3830497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Important melanocytic lesions in childhood and adolescence.
    Roth ME; Grant-Kels JM
    Pediatr Clin North Am; 1991 Aug; 38(4):791-809. PubMed ID: 1870906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysplastic nevi, melanoma and sunlight.
    Kraemer KH
    Photodermatol; 1987 Oct; 4(5):227-9. PubMed ID: 3697344
    [No Abstract]   [Full Text] [Related]  

  • 9. Dysplastic nevus--a risk factor of developing skin melanoma clinical and epidemiological study with retrospective review of literature.
    Marinković M; Janjić Z; Nikolić J
    Med Pregl; 2011; 64(5-6):315-8. PubMed ID: 21789925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large congenital melanocytic nevi, risk of cutaneous melanoma, and prophylactic surgery.
    Marghoob AA; Agero AL; Benvenuto-Andrade C; Dusza SW
    J Am Acad Dermatol; 2006 May; 54(5):868-70; discussion 871-3. PubMed ID: 16635668
    [No Abstract]   [Full Text] [Related]  

  • 11. Melanocytic nevi and malignant melanoma.
    Metcalf JS; Maize JC
    Dermatol Clin; 1985 Apr; 3(2):217-24. PubMed ID: 3830485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular findings in patients with dysplastic nevus syndrome. An update.
    Rodriguez-Sains RS
    Dermatol Clin; 1991 Oct; 9(4):723-8. PubMed ID: 1934647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dysplastic nevus syndrome: our definition.
    Elder DE; Green MH; Guerry D; Kraemer KH; Clark WH
    Am J Dermatopathol; 1982 Oct; 4(5):455-60. PubMed ID: 7149200
    [No Abstract]   [Full Text] [Related]  

  • 14. Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma - review article.
    Silva JH; Sá BC; Avila AL; Landman G; Duprat Neto JP
    Clinics (Sao Paulo); 2011; 66(3):493-9. PubMed ID: 21552679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysplastic nevi-dysplastic nevus syndromes: clinical features and genetic aspects.
    Weiss J; Garbe C; Büttner P; Jung EG
    Recent Results Cancer Res; 1993; 128():101-18. PubMed ID: 8356313
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk of cutaneous melanoma in dysplastic nevus syndrome types A and B.
    Kraemer KH; Tucker M; Tarone R; Elder DE; Clark WH
    N Engl J Med; 1986 Dec; 315(25):1615-6. PubMed ID: 3785330
    [No Abstract]   [Full Text] [Related]  

  • 17. The risk of melanoma and neurocutaneous melanosis associated with congenital melanocytic nevi.
    Shah KN
    Semin Cutan Med Surg; 2010 Sep; 29(3):159-64. PubMed ID: 21051009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Congenital melanocytic nevi--what should be said and done?].
    Lützow-Holm C; Helsing P
    Tidsskr Nor Laegeforen; 2003 May; 123(9):1204-5. PubMed ID: 12789791
    [No Abstract]   [Full Text] [Related]  

  • 19. De novo melanoma and melanoma arising from pre-existing nevus: in vivo morphologic differences as evaluated by confocal microscopy.
    Longo C; Rito C; Beretti F; Cesinaro AM; Piñeiro-Maceira J; Seidenari S; Pellacani G
    J Am Acad Dermatol; 2011 Sep; 65(3):604-614. PubMed ID: 21715047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysplastic nevi. Markers for increased risk for melanoma.
    Rigel DS; Rivers JK; Kopf AW; Friedman RJ; Vinokur AF; Heilman ER; Levenstein M
    Cancer; 1989 Jan; 63(2):386-9. PubMed ID: 2910446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.